Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Hydrus Microstent for Refractory Open-Angle Glaucoma: A Prospective, Multicenter Clinical Trial (Hydrus VII Study)

NCT03267134 is registered in ClinicalTrials.gov with Ivantis, Inc. as lead sponsor.

NCT NCT03267134
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03267134 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Hydrus Microstent for Refractory Open-Angle Glaucoma: A Prospective, Multicenter Clinical Trial (Hydrus VII Study)
Lead sponsor
Ivantis, Inc.
Phase
Not applicable
Overall status
Completed
Start date
August 1, 2017
Completion date
December 16, 2022
Enrollment
217 (actual)
Sites
20

Conditions

As the registry lists them; a condition with its own page is linked.

open-angle glaucoma